https://www.selleckchem.com/pr....oducts/gsk2879552-2h
Such an observation suggested that a combination of anlotinib with anti-cancer drugs could attenuate angiogenesis, metastasis, proliferative, and multidrug resistance, which constitutes a novel treatment strategy for CRC patients with metastasis.Objective To identify critical roles played by NEK2 in prolactinomas and to clarify the corresponding underlying mechanisms. Methods We performed RNA-seq on MMQ cell lines treated with the dopamine receptor agonist cabergoline (CA to identify genes involved in prolactinoma progression
כמו
תגובה
לַחֲלוֹק
